Board of Directors

Dr Amrein is a seasoned healthcare executive with more than 25 years of leadership and international experience across a variety of therapeutic areas. Prior to joining Stallergenes Greer, he was Managing Director and member of the Global Leadership Team at Advanced Clinical, a leading global contract research organisation. Dr. Amrein previously held positions of increasing responsibility, notably at Novartis, Abbott and Shire Takeda, where he accrued significant expertise in P&L leadership, specialising in commercial expansions, market entries, product launches, transformations, acquisitions, and integrations.

Dr Amrein is Swiss and holds a PhD in Health Economics, Evidence Based Medicine and Quality of Life for Rare Diseases from the University of Southern Queensland (Australia), an MBA from INSEAD (France) and a Master of Physics from ETH Zurich (Switzerland).

Pete has also served in several interim roles across B-Flexion including Interim Group Treasurer and Interim CFO at Boston Pharmaceuticals where he led execution of the successful sale of the company to GSK for $2 billion. He is Chairperson of the Board of Corium Therapeutics and a Board Member of Radius Health, Corium Innovations and Naveris.

Before joining B-Flexion, he was a consultant with the global leadership advisory firm Egon Zehnder’s Boston office where he advised private capital firms, their portfolio companies and Boards of Directors on talent, leadership, and strategy. Prior to Egon Zehnder, Pete spent nearly twenty years as an investor including seven years as a Partner at Caxton Associates in New York where he focused on fundamental and event driven investments across public and private credit and equity. At Caxton, Pete served on the firm’s Partnership and Risk Committees. He began his career building and leading proprietary trading businesses at global banks.

Pete earned his BA from Dartmouth College and his MBA from The Fuqua School of Business at Duke University. He is a CFA Charterholder, serves on the National Board of the educational access non-profit Minds Matter and the Boston Advisory Board of The Concussion Legacy Foundation.

He is Director and Head of Legal at BEMIDO SA (Swiss branch of the B-FLEXION Group), where he leads global legal and compliance activities, including corporate governance, regulatory compliance, anti-money laundering oversight, litigation management, and complex commercial and transactional contract negotiations. He brings a pragmatic, international, and business-focused approach to legal and governance advisory.

He advises senior management and boards on legal risk, structuring, and strategic matters, and serves as a board member or observer for entities in multiple jurisdictions. He also provides governance oversight for private philanthropic foundations and trusts.&nbsp;</p>

.Frédéric Boder holds a Geneva Bar qualification and a master’s degree in European law from the Université libre de Bruxelles.

Full-time roles include connection to a variety of organisations within Life Sciences, including Biotech, Healthcare IT, and Professional Services.  Steven Rotman joined the B-FLEXION team in 2022 and has been an active board member and advisor across the spectrum of the healthcare platform; Therapeutics, Diagnostics, Provider Practice Management, and others.

Before joining B-FLEXION, he was the Chief People & Engagement Officer at Karyopharm Therapeutics, a publicly-traded pharmaceutical organisation dedicated to the advancement of therapies in the oncology space. He also spent 10 years as the Vice President of Human Resources at NaviNet, an organisation with a commitment to link payors and providers in the US healthcare market. In addition to these full-time roles, he also serves on the President’s advisory board of the Whittier Street Health Center, a community-based provider serving tens of thousands of patients in one of the most underserviced neighborhoods in the region.

Steven Rotman compliments his professional experiences with a Bachelor’s Degree in Interpersonal Communication from the University of New Hampshire and a Master’s of Science Degree in Human Capital Management from Suffolk University.  There are also a number of local, charitable, and industry organisations that count him as a board member, advisor, and volunteer.